Purchases and Sales Made in Q1 2025 in Sage Therapeutics, Inc. (SAGE)
This table provides information about the institutional ownership of Sage Therapeutics, Inc. (SAGE) during Q1 2025. The information is specifically focused on institutions that hold shares of Sage Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2025
Q1 2025
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-60.4K- 43.21% |
$335K - $523K
|
79.4K
$725K
|
|
|
May 15, 2025
Q1 2025
|
State Street Corp
Boston, MA |
SELL
|
- |
-84.1K- 6.61% |
$467K - $728K
|
1.19M
$10.9M
|
|
|
May 13, 2025
Q1 2025
|
Ubs Group Ag
|
SELL
|
- |
-87.5K- 53.73% |
$486K - $758K
|
75.4K
$689K
|
|
|
May 09, 2025
Q1 2025
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-104K- 19.22% |
$578K - $902K
|
438K
$4M
|
|
|
May 15, 2025
Q1 2025
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-113K- 35.58% |
$625K - $976K
|
204K
$1.86M
|
|
|
May 15, 2025
Q1 2025
|
Pdt Partners, LLC
New York, NY |
SELL
|
- |
-119K- 50.43% |
$658K - $1.03M
|
117K
$1.07M
|
|
|
May 12, 2025
Q1 2025
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-155K- 85.42% |
$860K - $1.34M
|
26.4K
$242K
|
|
|
May 14, 2025
Q1 2025
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-269K- 58.19% |
$1.49M - $2.33M
|
193K
$1.77M
|
|
|
May 14, 2025
Q1 2025
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-375K- 90.54% |
$2.08M - $3.25M
|
39.2K
$358K
|
|
|
May 15, 2025
Q1 2025
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-417K- 37.12% |
$2.31M - $3.61M
|
706K
$6.46M
|
|
|
May 15, 2025
Q1 2025
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-1.31M- 80.94% |
$7.29M - $11.4M
|
310K
$2.83M
|
|
|
May 15, 2025
Q1 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-3.2M- 69.55% |
$17.7M - $27.7M
|
1.4M
$12.8M
|